MOSAICISM IN THE EXPRESSION OF TUMOR-ASSOCIATED CARBOHYDRATE ANTIGENS IN HUMAN COLONIC AND GASTRIC CANCERS
- 1 July 1989
- journal article
- research article
- Vol. 49 (13) , 3662-3669
Abstract
Serial sequential sections from a single tumor were examined by immunohistological staining with several monoclonal antibodies directed, respectively, to different tumor-associated carbohydrate epitopes. Staining patterns were compared with those of conventional staining with hematoxylin-eosin or periodate/Schiff''s reagent. Each tumor showed different areas of staining with different antibodies, and the combined staining map showes a clear mosaicism of antigen expression within the same tumor. For example, some areas of a given tumor were stained by FH4 (defining dimeric Lex), while other complementary areas were strongly stained, in a mutually exclusive manner, but SH1 (defining Lex), AH6 (defining Ley), FH6 (defining sialosyl dimeric Lex), or TKH2 (defining sialosyl-Tn). Some areas were stained by two or three of these antibodies. Comparisons of the mosaic-staining patterns with cytohistological properties of tumor cells within specific areas suggested that the pattern of antigen expression is correlated with degree of differentiation; e.g., poorly-differentiated cells with severe dysplasia did not express high levels of Lex or Ley but did express sialyl-Lex or dimeric Lex., on the other hand, moderately or well-differentiated tumor cells in some areas expressed high levels of Lex or Ley but lower levels of sialyl-Lex. Areas showing strong expression of sialyl-Tn in their secretions where consistently correlated with presence of well-differentiated tumor cells, whereas secretions from normal mucosae were consistently characterized by lack of sialyl-Tn expression. It is postulated that the original in situ tumors (which had homogeneous glycosylation patterns) evolved into several spatially discrete cell populations displaying different degrees of glycosylation, reflecting stages of tumor cell differentiation and progression.This publication has 19 references indexed in Scilit:
- Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.Proceedings of the National Academy of Sciences, 1985
- Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland.Journal of Biological Chemistry, 1984
- Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).Journal of Biological Chemistry, 1984
- Localization and alteration of mono-, di-, and trifucosyl alpha 1----3 type 2 chain structures during human embryogenesis and in human cancer.The Journal of Experimental Medicine, 1984
- The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant).Journal of Biological Chemistry, 1983
- Ganglioside GM2 as a human tumor antigen (OFA-I-1).Proceedings of the National Academy of Sciences, 1983
- A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.Journal of Biological Chemistry, 1982
- Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.Proceedings of the National Academy of Sciences, 1982
- Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2.Journal of Biological Chemistry, 1982
- GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.The Journal of Experimental Medicine, 1982